Mycobacterium tuberculosis Rv0309 Dampens the Inflammatory Response and Enhances Mycobacterial Survival

Area of Science:

• Microbiology
• Immunology
• Pathogenesis

Background:

• Understanding Mycobacterium tuberculosis (M. tb) proteins that modulate host innate immunity is crucial for elucidating mycobacterial pathogenesis.
• Novel M. tb proteins involved in immune evasion are key targets for therapeutic development.

Purpose of the Study:

• To identify the role of the putative M. tb protein Rv0309 in inhibiting host inflammatory responses.
• To elucidate the underlying molecular mechanisms by which Rv0309 affects innate immunity.

Main Methods:

• Construction of recombinant Mycobacterium smegmatis (Ms_rv0309) and mutant Bacillus Calmette-Guérin (BCGΔRS01790) strains.
• In vitro experiments using RAW264.7 cells to assess cytokine production and signaling pathways (NF-κB, MAPK).
• In vivo experiments in mice to evaluate host immune response and bacterial load.

Main Results:

• Rv0309 localizes to the cell wall and reduces its permeability.
• Recombinant Rv0309 and BCG_RS01790 inhibited pro-inflammatory cytokine (IL-6, IL-1β, TNF-α) production via NF-κB and MAPK signaling.
• Deletion of BCG_RS01790 in BCG led to increased cytokine production, reduced intracellular survival, and altered host immune responses in mice.
• Rv0309/BCG_RS01790 enhanced mycobacterial survival within macrophages.

Conclusions:

• The cell wall protein Rv0309 (or its BCG homologue BCG_RS01790) contributes to M. tb pathogenesis.
• Inhibition of pro-inflammatory responses and decreased bacterial cell wall permeability are key mechanisms.
• Rv0309 enhances intracellular survival of mycobacteria, promoting persistent infection.